Further study of changes in both NKA functioning and the amount of endogenous CTS in neurodegenerative disorders of the DA system, and mechanisms of CTS influence on the dopaminergic system in various models at the physiological, neurochemical, and biochemical levels could open up potential new pharmacological targets and biomarkers for both PD and affective disorders. This evidence concerns the gene TTR and Parkinson disease.